Lexicon Pharmaceuticals
LXRX
#5940
Rank
NZ$2.07 B
Marketcap
NZ$4.67
Share price
3.53%
Change (1 day)
198.05%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): NZ-$0.34

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$0.34. In 2024 the company made an earnings per share (EPS) of NZ-$1.13 an increase over its 2023 EPS that were of NZ-$1.41.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.34-70.35%
2024NZ-$1.13-20%
2023NZ-$1.4131.15%
2022NZ-$1.08-0%
2021NZ-$1.0810.91%
2020NZ-$0.97-145.08%
2019NZ$2.16-206.09%
2018NZ-$2.03-5.74%
2017NZ-$2.16-10.95%
2016NZ-$2.422640%
2015NZ-$0.08844-96.34%
2014NZ-$2.41-2.53%
2013NZ-$2.48-9.09%
2012NZ-$2.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$32.23-9,689.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$9.78-3,010.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$75.22-22,484.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ-$10.81 3,115.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$11.14-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.88 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ-$1.33 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.48-836.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ-$135.68 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA